NSCLC
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients who underwent thoracoscopic lobectomy, lobectomy, compound lobectomy or total lobectomy with or without mediastinal lymph node resection; (2) Postoperative pathological diagnosis was primary non-small cell lung cancer stage I, ? a or carcinoma in situ; (3) There was no chest pain before operation, but within 3 months after operation; (4) They were 18-85 years old; (5) Willing to participate in clinical trials, signed informed consent, and can contact follow-up Only those who meet all the above conditions can be included in the study
Exclusion criteria
Exclusion criteria: (1) Lung secondary malignant tumor patients; (2) Patients with severe primary diseases such as heart, brain, kidney; (3) Psychotic patients; (4) Those who meet the diagnostic criteria of non-small cell lung cancer but have undergone surgery, radiotherapy, chemotherapy, targeted therapy and received traditional Chinese medicine treatment in recent 3 months; Those who met any of the above criteria could not be included in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effective rate of pain improvement;Quality of life score;Cough score;TCM syndrome integral; | — |
Countries
China